1-7 of 7
stroke prevention
Close
Sort by
Journal Articles

Prevention of central nervous system sequelae in sickle cell disease without evidence from randomized controlled trials: the case for a team-based learning collaborative

Michael R. DeBaun, Allison A. King
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2016) 2016 (1): 632–639.
https://doi.org/10.1182/asheducation-2016.1.632
Published: 2016
Journal Articles

Monitoring target-specific oral anticoagulants

Barbara A. Konkle
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2014) 2014 (1): 329–333.
https://doi.org/10.1182/asheducation-2014.1.329
Published: 2014
Journal Articles

Pros and cons of new oral anticoagulants

Kenneth A. Bauer
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2013) 2013 (1): 464–470.
https://doi.org/10.1182/asheducation-2013.1.464
Published: 2013
Journal Articles

What Is the Evidence for Using Hydroxyurea for Secondary Stroke Prevention?

Jeffrey D. Lebensburger, Michael R. DeBaun, Alexis A. Thompson
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2011) 2011 (1): 440–442.
https://doi.org/10.1182/asheducation-2011.1.440
Published: 2011
Journal Articles

New Issues in Oral Anticoagulants

Charles W. Francis
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2008) 2008 (1): 259–265.
https://doi.org/10.1182/asheducation-2008.1.259
Published: 2008
Journal Articles

Limitations of Clinical Trials in Sickle Cell Disease: A Case Study of the Multi-center Study of Hydroxyurea (MSH) Trial and the Stroke Prevention (STOP) Trial

Michael R. DeBaun, Joshua J. Field
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2007) 2007 (1): 482–488.
https://doi.org/10.1182/asheducation-2007.1.482
Published: 2007
Journal Articles

New Anticoagulants

Kenneth A. Bauer
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2006) 2006 (1): 450–456.
https://doi.org/10.1182/asheducation-2006.1.450
Published: 2006